PTIX
Price
$0.37
Change
-$0.05 (-11.90%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
2.81M
SCPX
Price
$0.13
Change
-$0.00 (-0.00%)
Updated
Apr 4, 04:54 PM (EDT)
Capitalization
769.64K
Ad is loading...

PTIX vs SCPX

Header iconPTIX vs SCPX Comparison
Open Charts PTIX vs SCPXBanner chart's image
Protagenic Therapeutics
Price$0.37
Change-$0.05 (-11.90%)
Volume$12.11K
Capitalization2.81M
SCORPIUS HOLDINGS
Price$0.13
Change-$0.00 (-0.00%)
Volume$8.73K
Capitalization769.64K
PTIX vs SCPX Comparison Chart
Loading...
PTIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PTIX vs. SCPX commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PTIX is a Hold and SCPX is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (PTIX: $0.42 vs. SCPX: $0.13)
Brand notoriety: PTIX and SCPX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PTIX: 2629% vs. SCPX: 47%
Market capitalization -- PTIX: $3.02M vs. SCPX: $769.64K
PTIX [@Biotechnology] is valued at $3.02M. SCPX’s [@Biotechnology] market capitalization is $769.64K. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PTIX’s FA Score shows that 0 FA rating(s) are green whileSCPX’s FA Score has 1 green FA rating(s).

  • PTIX’s FA Score: 0 green, 5 red.
  • SCPX’s FA Score: 1 green, 4 red.
According to our system of comparison, SCPX is a better buy in the long-term than PTIX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PTIX’s TA Score shows that 5 TA indicator(s) are bullish while SCPX’s TA Score has 5 bullish TA indicator(s).

  • PTIX’s TA Score: 5 bullish, 4 bearish.
  • SCPX’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, SCPX is a better buy in the short-term than PTIX.

Price Growth

PTIX (@Biotechnology) experienced а +67.20% price change this week, while SCPX (@Biotechnology) price change was -14.97% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -10.73%. For the same industry, the average monthly price growth was -16.65%, and the average quarterly price growth was -18.36%.

Reported Earning Dates

PTIX is expected to report earnings on May 31, 2023.

SCPX is expected to report earnings on Nov 11, 2024.

Industries' Descriptions

@Biotechnology (-10.73% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PTIX($2.81M) has a higher market cap than SCPX($770K). PTIX YTD gains are higher at: -14.694 vs. SCPX (-59.545). PTIX has higher annual earnings (EBITDA): -5.57M vs. SCPX (-22.84M). SCPX has more cash in the bank: 4.81M vs. PTIX (1.06M). PTIX has less debt than SCPX: PTIX (420K) vs SCPX (14.9M). SCPX has higher revenues than PTIX: SCPX (10M) vs PTIX (0).
PTIXSCPXPTIX / SCPX
Capitalization2.81M770K365%
EBITDA-5.57M-22.84M24%
Gain YTD-14.694-59.54525%
P/E RatioN/AN/A-
Revenue010M-
Total Cash1.06M4.81M22%
Total Debt420K14.9M3%
FUNDAMENTALS RATINGS
PTIX vs SCPX: Fundamental Ratings
PTIX
SCPX
OUTLOOK RATING
1..100
9358
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
7
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10098
PRICE GROWTH RATING
1..100
9596
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SCPX's Valuation (7) in the Biotechnology industry is somewhat better than the same rating for PTIX (51) in the null industry. This means that SCPX’s stock grew somewhat faster than PTIX’s over the last 12 months.

SCPX's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PTIX (100) in the null industry. This means that SCPX’s stock grew similarly to PTIX’s over the last 12 months.

SCPX's SMR Rating (98) in the Biotechnology industry is in the same range as PTIX (100) in the null industry. This means that SCPX’s stock grew similarly to PTIX’s over the last 12 months.

PTIX's Price Growth Rating (95) in the null industry is in the same range as SCPX (96) in the Biotechnology industry. This means that PTIX’s stock grew similarly to SCPX’s over the last 12 months.

PTIX's P/E Growth Rating (100) in the null industry is in the same range as SCPX (100) in the Biotechnology industry. This means that PTIX’s stock grew similarly to SCPX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
PTIXSCPX
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
75%
Momentum
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
MACD
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 15 days ago
86%
Bullish Trend 16 days ago
76%
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
PTIX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SCPX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PRPPX13.65N/A
N/A
Principal International Equity R3
SWANX22.17N/A
N/A
Schwab Core Equity
EMGRX9.64N/A
N/A
Nuveen Small Cap Select A
LHCAX18.18N/A
N/A
Lord Abbett Health Care A
IDHCX17.93-0.64
-3.45%
Integrity Dividend Harvest C

PTIX and

Correlation & Price change

A.I.dvisor tells us that PTIX and SCPX have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PTIX and SCPX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PTIX
1D Price
Change %
PTIX100%
+84.14%
SCPX - PTIX
27%
Poorly correlated
-3.26%
SQZB - PTIX
26%
Poorly correlated
N/A
CDTX - PTIX
25%
Poorly correlated
N/A
OCGN - PTIX
25%
Poorly correlated
-7.30%
BPTSY - PTIX
24%
Poorly correlated
N/A
More